DashboardAll companies
Run this on your own research
Healthcare · Biotechnology

Sk Bioscience Co., Ltd.

302440KRX₩32,750+₩550 (+1.71%)Market closed

Price Chart

Daily

Key facts

Market Cap
₩2.57T
P/E
−44.7x
P/B
1.43x
ROE
−3.2%

Sk Bioscience Co., Ltd.

Healthcare · Biotechnology · FY 2025

Sk Bioscience Co., Ltd. is a South Korean biopharmaceutical company that specializes in the development, manufacturing, and distribution of vaccines. As a key player in the healthcare sector, the company's primary focus is on providing high-quality vaccines that address various infectious diseases globally. Sk Bioscience Co., Ltd. is renowned for its advanced research and development capabilities, which have positioned it at the forefront of the vaccine industry. Its portfolio includes a range of products for both the domestic and international markets, supported by state-of-the-art production facilities and rigorous compliance with international quality standards. The company's strategic partnerships with global health organizations and its commitment to innovation underscore its influential role in advancing public health through preventive care solutions. Operating within the dynamic life sciences industry, Sk Bioscience Co., Ltd. continues to contribute significantly to the development and accessibility of essential vaccines worldwide.

CEO
안재용
Employees
917

Company Statistics

Valuation

P/E
−44.7x
P/B
1.43x
P/S
3.94x
EV/EBITDA
−118.6x
P/FCF
−16.3x

Margins

Gross
11.7%
EBITDA
−4.1%
Operating
−19.0%
Pre-Tax
−13.2%
Net
−8.6%

Returns

ROA
−1.9%
ROE
−3.2%
ROIC
−2.6%

Growth (CAGR)

Rev 3Yr
12.6%
Rev 5Yr
23.6%
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
₩105.55B
Net Debt
₩812.74B
Debt/Equity
45.1%
Interest Cov
—

Profile

Revenue
₩651.37B
Shares Out
78.5M
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Sk Bioscience Co., Ltd. (302440) Stock Forecast 2026 ₩32,750 — Price, Financials & Analyst Targets | AlphaLenz